Evidence map›Paper›PMID 32973201›Full record

ArticleScientific reports2020

Osteopontin regulates biomimetic calcium phosphate crystallization from disordered mineral layers covering apatite crystallites.

Taly Iline-Vul, Raju Nanda, Borja Mateos, Shani Hazan, Irina Matlahov, Ilana Perelshtein, Keren Keinan-Adamsky, Gerhard Althoff-Ospelt, Robert Konrat, Gil Goobes

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Nuclear Magnetic Resonance and Metadynamics Simulations Reveal the Atomistic Binding of l-Serine andChemistry of materials : a publication of the American Chemical Society · 2022
    Article
  12. Amyloid-like amelogenin nanoribbons template mineralization via a low-energy interface of ion binding sites.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Taly Iline-VulDepartment of Chemistry, Bar Ilan University, 5290002, Ramat Gan, Israel.
Raju NandaDepartment of Chemistry, Bar Ilan University, 5290002, Ramat Gan, Israel.
Borja MateosMax F. Perutz Laboratories, Department of Computational and Structural Biology, University of Vienna, 1030, Vienna, Austria.
Shani HazanDepartment of Chemistry, Bar Ilan University, 5290002, Ramat Gan, Israel.
Irina MatlahovDepartment of Chemistry, Bar Ilan University, 5290002, Ramat Gan, Israel.
Ilana PerelshteinDepartment of Chemistry, Bar Ilan University, 5290002, Ramat Gan, Israel.
Keren Keinan-AdamskyDepartment of Chemistry, Bar Ilan University, 5290002, Ramat Gan, Israel.
Gerhard Althoff-OspeltSolid-State NMR Application, Bruker Biospin GmbH, Rheinstetten, Germany.
Robert KonratMax F. Perutz Laboratories, Department of Computational and Structural Biology, University of Vienna, 1030, Vienna, Austria.
Gil GoobesDepartment of Chemistry, Bar Ilan University, 5290002, Ramat Gan, Israel. gil.goobes@biu.ac.il.
Bar-Ilan University · ILBruker (Germany) · DEMax Perutz Labs · ATUniversity of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Details of apatite formation and development in bone below the nanometer scale remain enigmatic. Regulation of mineralization was shown to be governed by the activity of non-collagenous proteins with many bone diseases stemming from improper activity of these proteins. Apatite crystal growth inhibition or enhancement is thought to involve direct interaction of these proteins with exposed faces of apatite crystals. However, experimental evidence of the molecular binding events that occur and that allow these proteins to exert their functions are lacking. Moreover, recent high-resolution measurements of apatite crystallites in bone have shown that individual crystallites are covered by a persistent layer of amorphous calcium phosphate. It is therefore unclear whether non-collagenous proteins can interact with the faces of the mineral crystallites directly and what are the consequences of the presence of a disordered mineral layer to their functionality. In this work, the regulatory effect of recombinant osteopontin on biomimetic apatite is shown to produce platelet-shaped apatite crystallites with disordered layers coating them. The protein is also shown to regulate the content and properties of the disordered mineral phase (and sublayers within it). Through solid-state NMR atomic carbon-phosphorous distance measurements, the protein is shown to be located in the disordered phases, reaching out to interact with the surfaces of the crystals only through very few sidechains. These observations suggest that non-phosphorylated osteopontin acts as regulator of the coating mineral layers and exerts its effect on apatite crystal growth processes mostly from afar with a limited number of contact points with the crystal.

Indexed as

BiomimeticsApatitesCalcification, PhysiologicCalcium PhosphatesCrystallizationOsteopontinSurface Propertiesamorphous calcium phosphateApatitesCalcium PhosphatesOsteopontin

Identifiers

PMID32973201
PMCPMC7518277
OpenAlexW3087800762

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.